Beijing HOPE Pharmaceutical Co., Ltd. (stock number 836438), founded in 2005 and locatedat Beijing Economic-technological Development Area, is a state level high-tech enterprisededicated to the development of chemical drugs. Hope has the right of dealing self-managedimp& exp business. The main business are R&D, technology transfer and technical services ofAPIs and pharmaceutical preparations; R&D, manufacture and sales of PIs.

Hope has a high-level R&D team and a strict R&D, manufacture and service managementsystem. Depending on many years of technology accumulation, Hope has been designated as“high-tech enterprise”and“Beijing scientific and technological organization for R&D”.

Hope has always been adhering to the technology-oriented, talent-based policy since itsestablishment. By a huge investment in R&D of new drugs for the treatment of tumor,depression, cardio-cerebrovascular diseases, gastrointestinal diseases, respiratory disease,etc., By now, Hope has already obtained more than ten innovation patents, ten new drugcertificates, ten manufacturing approval certificates and 40 approvals for clinical trials.

Beijing HMT Medical Technology Co., Ltd. (HMT) is a wholly owned subsidiary of Hopespecialized in R&D, manufacture, sales of Pharmaceutical Intermediates (PIs) and isoriented towards the global market. Depending on many years’experience in drug R&Dand registration, we can provide our client not only the high-quality products, but alsocomprehensive technical and document support to assist them in solving the problems.